LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
gb gb gb gb gb gb gb gb gb
TEST BANK gb
Pharmacology and the Nursing Process
gb gb gb gb
9th Edition
gb
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
gb gb gb gb gb gb gb gb
NURSINGTB.COM
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
gb gb gb gb gb gb gb gb gb
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
gb gb gb gb gb gb gb
Chapter 02: Pharmacologic Principles .......................................................................................................... 8
gb gb gb
Chapter 03: Lifespan Considerations .......................................................................................................... 14
gb gb gb
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................. 20
gb gb gb gb gb gb
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
gb gb gb gb gb gb
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
gb gb gb gb gb gb
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................... 34
gb gb gb gb gb gb gb gb
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
gb gb gb gb gb
Chapter 09: Photo Atlas of Drug Administration ........................................................................................ 41
gb gb gb gb gb gb
Chapter 10: Analgesic Drugs ...................................................................................................................... 50
gb gb gb
Chapter 11: General and Local Anesthetics ................................................................................................ 57
gb gb gb gb gb
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ................................................... 61
gb gb gb gb gb gb gb gb
Chapter 13: Central Nervous System Stimulants and Related Drugs ........................................................... 66
gb gb gb gb gb gb gb gb
Chapter 14: Antiepileptic Drugs ................................................................................................................. 70
gb gb gb
Chapter 15: Antiparkinson D r u g s . . . . . . . .. . . . . .. . . .N. .U. . .R. .S. .I. N
gb gb . . .G. . .T. .B. . ..C. . .O. . M............................................ 76
gb
Chapter 16: Psychotherapeutic Drugs ........................................................................................................ 81
gb gb gb
Chapter 17: Substance Use Disorder.......................................................................................................... 88
gb gb gb gb
Chapter 18: Adrenergic Drugs .................................................................................................................... 93
gb gb gb
Chapter 19: Adrenergic-Blocking Drugs ..................................................................................................... 98
gb gb gb
Chapter 20: Cholinergic Drugs ..................................................................................................................103
gb gb gb
Chapter 21: Cholinergic-Blocking Drugs ....................................................................................................108
gb gb gb
Chapter 22: Antihypertensive Drugs .........................................................................................................113
gb gb gb
Chapter 23: Antianginal Drugs ..................................................................................................................119
gb gb gb
Chapter 24: Heart Failure Drugs ...............................................................................................................125
gb gb gb gb
Chapter 25: Antidysrhythmic Drugs ..........................................................................................................131
gb gb gb
Chapter 26: Coagulation Modifier Drugs ...................................................................................................137
gb gb gb gb
Chapter 27: Antilipemic Drugs ..................................................................................................................143
gb gb gb
Chapter 28: Diuretic Drugs ........................................................................................................................148
gb gb gb
Chapter 29: Fluids and Electrolytes ...........................................................................................................154
gb gb gb gb
Chapter 30: Pituitary Drugs.......................................................................................................................160
gb gb gb
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
gb gb gb gb gb gb gb gb gb
Chapter 31: Thyroid and Antithyroid Drugs ...............................................................................................163
gb gb gb gb gb
Chapter 32: Antidiabetic Drugs .................................................................................................................168
gb gb gb
Chapter 33: Adrenal Drugs........................................................................................................................177
gb gb gb
Chapter 34: Women’s Health Drugs ..........................................................................................................181
gb gb gb gb
Chapter 35: Men’s Health Drugs ...............................................................................................................188
gb gb gb gb
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ............................................193
gb gb gb gb gb gb
Chapter 37: Respiratory Drugs ..................................................................................................................198
gb gb gb
Chapter 38: Antibiotics Part 1 ...................................................................................................................204
gb gb gb gb
Chapter 39: Antibiotics Part 2 ...................................................................................................................211
gb gb gb gb
Chapter 40: Antiviral Drugs .......................................................................................................................216
gb gb gb
Chapter 41: Antitubercular Drugs .............................................................................................................221
gb gb gb
Chapter 42: Antifungal Drugs ....................................................................................................................226
gb gb gb
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs .............................................................231
gb gb gb gb gb gb
Chapter 44: Anti-inflammatory and Antigout Drugs ..................................................................................236
gb gb gb gb gb
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs .........................242
gb gb gb gb gb gb gb gb gb gb gb
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .............248
gb gb gb gb gb gb gb gb gb gb gb
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ........................................................253
gb gb gb gb gb gb
Chapter 48: Immunosuppressant Drugs....................................................................................................258
gb gb gb
Chapter 49: Immunizing Drugs..................................................................................................................263
gb gb gb
Chapter 50: Acid-Controlling Drugs ...........................................................................................................268
gb gb gb
Chapter 51: Bowel Disorder Drugs ............................................................................................................274
gb gb gb gb
Chapter 52: Antiemetic and Antinausea Drugs ..........................................................................................281
gb gb gb gb gb
Chapter 53: Vitamins and Minerals ...........................................................................................................286
gb gb gb gb
Chapter 54: Anemia Drugs ........................................................................................................................292
gb gb gb
Chapter 55: Nutritional Supplements .......................................................................................................299
gb gb gb
Chapter 56: Dermatologic Drugs ...............................................................................................................304
gb gb gb
Chapter 57: Ophthalmic Drugs ..................................................................................................................310
gb gb gb
Chapter 58: Otic Drugs ..............................................................................................................................315
gb gb gb
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK gb gb gb gb gb gb gb gb gb
Chapter 01: The Nursing Process and Drug Therapy gb gb gb gb gb gb gb g b g b 4
Chapter 01: The Nursing Process and Drug Therapy gb gb gb gb gb gb gb
MULTIPLE CHOICE gb
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
diagnosis?
gb
a. Anxiety
b. Anxiety related to new drug therapy gb gb gb gb gb
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
gb gb gb gb gb gb gb gb gb gb gb
such as “I’m upset about having to test my blood sugars.”
gb gb gb gb gb gb gb gb gb gb
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
gb gb gb gb gb gb gb gb gb gb gb gb
upset about having to test my blood sugars.” gb gb gb gb gb gb gb
ANS: g b D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
gb gb gb gb gb gb gb gb gb gb gb gb
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
gb gb gb gb gb gb gb gb gb gb gb gb gb
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
DIF: COGNITIVE LEVEL: Understanding (Comprehension) gb gb gb
TOP: NURSING PROCESS: Nursing
gb g b gb gb
DiagNnUosRiSs INGTB.COM
gb
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
g b gb gb gb gb gb gb gb gb
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
represent?
gb
a. “Right time” gb
b. “Right dose” gb
c. “Right route” gb
d. “Right medication” gb
ANS: g b A
“Right time” is correct because the medication was given more than 30 minutes after the
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
medication administration is scheduled. “Route” is incorrect because the route is not affected.
gb gb gb gb gb gb gb gb gb gb gb gb
“Medication” is incorrect because the medication ordered will not change.
gb gb gb gb gb gb gb gb gb gb
DIF: COGNITIVE LEVEL: Applying (Application) gb gb gb
TOP: NURSING PROCESS: Implementation
gb g b gb gb
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
g b gb gb gb gb gb gb gb gb gb
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
and documenting the patient’s therapeutic response to the medication. Which phase of the
gb gb gb gb gb gb gb gb gb gb gb gb gb
nursing process do these actions illustrate?
gb gb gb gb gb gb
a. Nursing diagnosis gb
NURSINGTB.COM
gb gb gb gb gb gb gb gb gb
TEST BANK gb
Pharmacology and the Nursing Process
gb gb gb gb
9th Edition
gb
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
gb gb gb gb gb gb gb gb
NURSINGTB.COM
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
gb gb gb gb gb gb gb gb gb
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
gb gb gb gb gb gb gb
Chapter 02: Pharmacologic Principles .......................................................................................................... 8
gb gb gb
Chapter 03: Lifespan Considerations .......................................................................................................... 14
gb gb gb
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................. 20
gb gb gb gb gb gb
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
gb gb gb gb gb gb
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
gb gb gb gb gb gb
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................... 34
gb gb gb gb gb gb gb gb
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
gb gb gb gb gb
Chapter 09: Photo Atlas of Drug Administration ........................................................................................ 41
gb gb gb gb gb gb
Chapter 10: Analgesic Drugs ...................................................................................................................... 50
gb gb gb
Chapter 11: General and Local Anesthetics ................................................................................................ 57
gb gb gb gb gb
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ................................................... 61
gb gb gb gb gb gb gb gb
Chapter 13: Central Nervous System Stimulants and Related Drugs ........................................................... 66
gb gb gb gb gb gb gb gb
Chapter 14: Antiepileptic Drugs ................................................................................................................. 70
gb gb gb
Chapter 15: Antiparkinson D r u g s . . . . . . . .. . . . . .. . . .N. .U. . .R. .S. .I. N
gb gb . . .G. . .T. .B. . ..C. . .O. . M............................................ 76
gb
Chapter 16: Psychotherapeutic Drugs ........................................................................................................ 81
gb gb gb
Chapter 17: Substance Use Disorder.......................................................................................................... 88
gb gb gb gb
Chapter 18: Adrenergic Drugs .................................................................................................................... 93
gb gb gb
Chapter 19: Adrenergic-Blocking Drugs ..................................................................................................... 98
gb gb gb
Chapter 20: Cholinergic Drugs ..................................................................................................................103
gb gb gb
Chapter 21: Cholinergic-Blocking Drugs ....................................................................................................108
gb gb gb
Chapter 22: Antihypertensive Drugs .........................................................................................................113
gb gb gb
Chapter 23: Antianginal Drugs ..................................................................................................................119
gb gb gb
Chapter 24: Heart Failure Drugs ...............................................................................................................125
gb gb gb gb
Chapter 25: Antidysrhythmic Drugs ..........................................................................................................131
gb gb gb
Chapter 26: Coagulation Modifier Drugs ...................................................................................................137
gb gb gb gb
Chapter 27: Antilipemic Drugs ..................................................................................................................143
gb gb gb
Chapter 28: Diuretic Drugs ........................................................................................................................148
gb gb gb
Chapter 29: Fluids and Electrolytes ...........................................................................................................154
gb gb gb gb
Chapter 30: Pituitary Drugs.......................................................................................................................160
gb gb gb
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
gb gb gb gb gb gb gb gb gb
Chapter 31: Thyroid and Antithyroid Drugs ...............................................................................................163
gb gb gb gb gb
Chapter 32: Antidiabetic Drugs .................................................................................................................168
gb gb gb
Chapter 33: Adrenal Drugs........................................................................................................................177
gb gb gb
Chapter 34: Women’s Health Drugs ..........................................................................................................181
gb gb gb gb
Chapter 35: Men’s Health Drugs ...............................................................................................................188
gb gb gb gb
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ............................................193
gb gb gb gb gb gb
Chapter 37: Respiratory Drugs ..................................................................................................................198
gb gb gb
Chapter 38: Antibiotics Part 1 ...................................................................................................................204
gb gb gb gb
Chapter 39: Antibiotics Part 2 ...................................................................................................................211
gb gb gb gb
Chapter 40: Antiviral Drugs .......................................................................................................................216
gb gb gb
Chapter 41: Antitubercular Drugs .............................................................................................................221
gb gb gb
Chapter 42: Antifungal Drugs ....................................................................................................................226
gb gb gb
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs .............................................................231
gb gb gb gb gb gb
Chapter 44: Anti-inflammatory and Antigout Drugs ..................................................................................236
gb gb gb gb gb
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs .........................242
gb gb gb gb gb gb gb gb gb gb gb
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .............248
gb gb gb gb gb gb gb gb gb gb gb
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ........................................................253
gb gb gb gb gb gb
Chapter 48: Immunosuppressant Drugs....................................................................................................258
gb gb gb
Chapter 49: Immunizing Drugs..................................................................................................................263
gb gb gb
Chapter 50: Acid-Controlling Drugs ...........................................................................................................268
gb gb gb
Chapter 51: Bowel Disorder Drugs ............................................................................................................274
gb gb gb gb
Chapter 52: Antiemetic and Antinausea Drugs ..........................................................................................281
gb gb gb gb gb
Chapter 53: Vitamins and Minerals ...........................................................................................................286
gb gb gb gb
Chapter 54: Anemia Drugs ........................................................................................................................292
gb gb gb
Chapter 55: Nutritional Supplements .......................................................................................................299
gb gb gb
Chapter 56: Dermatologic Drugs ...............................................................................................................304
gb gb gb
Chapter 57: Ophthalmic Drugs ..................................................................................................................310
gb gb gb
Chapter 58: Otic Drugs ..............................................................................................................................315
gb gb gb
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK gb gb gb gb gb gb gb gb gb
Chapter 01: The Nursing Process and Drug Therapy gb gb gb gb gb gb gb g b g b 4
Chapter 01: The Nursing Process and Drug Therapy gb gb gb gb gb gb gb
MULTIPLE CHOICE gb
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
diagnosis?
gb
a. Anxiety
b. Anxiety related to new drug therapy gb gb gb gb gb
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
gb gb gb gb gb gb gb gb gb gb gb
such as “I’m upset about having to test my blood sugars.”
gb gb gb gb gb gb gb gb gb gb
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
gb gb gb gb gb gb gb gb gb gb gb gb
upset about having to test my blood sugars.” gb gb gb gb gb gb gb
ANS: g b D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the
gb gb gb gb gb gb gb gb gb gb gb gb
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new
gb gb gb gb gb gb gb gb gb gb gb gb gb
drug therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
DIF: COGNITIVE LEVEL: Understanding (Comprehension) gb gb gb
TOP: NURSING PROCESS: Nursing
gb g b gb gb
DiagNnUosRiSs INGTB.COM
gb
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
g b gb gb gb gb gb gb gb gb
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
represent?
gb
a. “Right time” gb
b. “Right dose” gb
c. “Right route” gb
d. “Right medication” gb
ANS: g b A
“Right time” is correct because the medication was given more than 30 minutes after the
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
medication administration is scheduled. “Route” is incorrect because the route is not affected.
gb gb gb gb gb gb gb gb gb gb gb gb
“Medication” is incorrect because the medication ordered will not change.
gb gb gb gb gb gb gb gb gb gb
DIF: COGNITIVE LEVEL: Applying (Application) gb gb gb
TOP: NURSING PROCESS: Implementation
gb g b gb gb
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
g b gb gb gb gb gb gb gb gb gb
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb gb
and documenting the patient’s therapeutic response to the medication. Which phase of the
gb gb gb gb gb gb gb gb gb gb gb gb gb
nursing process do these actions illustrate?
gb gb gb gb gb gb
a. Nursing diagnosis gb
NURSINGTB.COM
